This week, 3 Pharmaceuticals stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
The rating of Medicines Company (MDCO) moves up this week, rising from a C to a B. Medicines Company develops products that improve specialized care. The company also gets A’s in earnings revisions and earnings momentum. For more information, get Portfolio Grader’s complete analysis of MDCO stock.
Nektar Therapeutics (NKTR) boosts its rating from a C to a B this week. Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The company also gets A’s in earnings surprise. For more information, get Portfolio Grader’s complete analysis of NKTR stock.
BioStar Pharmaceuticals, Inc. (BSPM) gets a higher grade this week, advancing from a C last week to a B. BioStar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products, and health supplement products for various diseases and conditions in the Peoples Republic of China. For more information, get Portfolio Grader’s complete analysis of BSPM stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.